1-methyltryptophan has been researched along with Cancer of Ovary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q; Ma, H; Mi, J; Qin, Q | 1 |
| Andrews, C; Ayyoub, M; Beck, A; Cheney, R; Frederick, PJ; Lele, S; Liao, J; Matsuzaki, J; Mhawech-Fauceglia, P; Moysich, K; Odunsi, K; Old, LJ; Qian, F; Shrikant, P; Tario, JD; Valmori, D; Villella, J; Wallace, PK | 1 |
| Akimoto, H; Inaba, T; Ino, K; Kajiyama, H; Kikkawa, F; Nagasaka, T; Nawa, A; Shibata, K; Takikawa, O; Yamamoto, E | 1 |
| Nelson, BH | 1 |
4 other study(ies) available for 1-methyltryptophan and Cancer of Ovary
| Article | Year |
|---|---|
1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function.
Topics: Antineoplastic Agents; Carboplatin; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Killer Cells, Natural; Ovarian Neoplasms; Tryptophan | 2020 |
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.
Topics: Cell Division; Cell Line; Epithelial Cells; Female; Flow Cytometry; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kidney; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Ovarian Neoplasms; Stereoisomerism; T-Lymphocytes; Transfection; Tryptophan | 2009 |
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Progression; Drug Synergism; Female; Humans; Immunohistochemistry; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Transfection; Tryptophan; Xenograft Model Antitumor Assays | 2009 |
IDO and outcomes in ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Drug Synergism; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lymphocytes, Tumor-Infiltrating; Ovarian Neoplasms; Paclitaxel; Prognosis; Tryptophan | 2009 |